FDA — authorised 26 May 1953
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: approved
🇺🇸 Thyrogen in United States
FDA authorised Thyrogen on 26 May 1953
Marketing authorisations
FDA — authorised 12 August 2008
- Application: BLA020898
- Marketing authorisation holder: GENZYME
- Indication: Labeling
- Status: approved
Thyrogen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Thyrogen approved in United States?
Yes. FDA authorised it on 26 May 1953; FDA authorised it on 12 August 2008.
Who is the marketing authorisation holder for Thyrogen in United States?
SANOFI AVENTIS US holds the US marketing authorisation.